Brief: Vaxil Bio Ltd Commences In Vivo (Animal) Study For Covid-19 Vaccine Candidate

Vaxil Bio

20/07/2020 14:10

July 20 (Reuters) - Vaxil Bio Ltd  VXL.V :
    * VAXIL BIO LTD - COMMENCED IN VIVO (ANIMAL) STUDY FOR OUR
COVID-19 VACCINE CANDIDATE
    * VAXIL BIO LTD - FIRST ANIMAL INJECTION WAS ADMINISTERED ON
JULY
14
    * VAXIL BIO - HAS SUFFICIENT FUNDS TO COMPLETE COLLABORATION
WORK
WITH TEL AVIV MEDICAL CENTER
    * VAXIL BIO LTD - IS ENTERING INTO A MEDIATION WITH A FORMER
OFFICER OF CO IN CONNECTION WITH A DISAGREEMENT REGARDING
COMPENSATION
    * VAXIL BIO - SEEKS TO RAISE ADDITIONAL FUNDS TO PURSUE
OTHER
INNOVATIVE PROGRAMS IN ONCOLOGY AND INFECTIOUS DISEASES

Source text for Eikon:  ID:nGNXbNmk6B 
Further company coverage:  VXL.V 

 ((Reuters.Briefs@thomsonreuters.com;))